Trial Profile
Effect of minodronate for preventring secondary fragility fractures in postoperative hip fractures of oseteoporotic patients.
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 18 Aug 2015
Price :
$35
*
At a glance
- Drugs Minodronic acid (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- 18 Aug 2015 New trial record